Id Counterfeit Pharmaceuticals with Portable Raman
Rigaku
| « Previous month | Next month » |
30-Jun-2004
Borculo boosts German distribution
30-Jun-2004 - Borculo Domo has appointed a new German distributor to handle its range of pharmaceutical-grade lactose excipients.
Conveyor suits pharma packagers
30-Jun-2004 - A new customisable conveyor system, specifically designed to meet the regulatory demands on packaging in the pharmaceutical industry, has been launched by AutoPak Engineering.
Polymer drug delivery deal for OctoPlus
30-Jun-2004 - Dutch drug delivery company OctoPlus has licensed two biodegradeable polymers to SurModics that can be used to coat medical devices and deliver drugs into the surrounding tissues.
RSV drug clears Phase I
30-Jun-2004 - A compound targetting respiratory syncytial virus - a major threat to immunocompromised patients - has completed Phase I trials, raising hopes of the first effective treatment for the virus, writes...
Falling citric acid prices claim Belgian casualties
30-Jun-2004 - Pricing pressure on the global market for citric acid has forced DSM of the Netherlands to lay off staff at its Citrique Belge unit, reports Phil Taylor.
Alzheimer's disease vaccine a step nearer?
30-Jun-2004 - Researchers in the US have taken an important step toward creating a vaccine against Alzheimer's disease, overcoming the side effects that held back a prior vaccine for the disease.
Pharma cos face rising waste disposal costs
30-Jun-2004 - UK companies producing hazardous waste - including the pharmaceutical industry - are facing a dramatic reduction in the number of landfill sites in the UK that will accept the material.
RNAi alliance targets blindness
30-Jun-2004 - A new alliance between Merck & Co and Alnylam, a specialist in the development of therapeutics based on RNA interference (RNAi) could fast-track the first drug in this class though...
Generic growth bodes well for vendor firms
30-Jun-2004 - The market for generic drugs is going to expand from its present level of $35 billion (€29bn) to $80 billion in 2008, as cash-strapped healthcare payors turn increasingly to cheaper options.
29-Jun-2004
Cardinal close to completing Alaris buy
29-Jun-2004 - Cardinal Health has completed its $2 billion (€1.6bn) tender offer for intravenous product and services firm Alaris Medical Systems in a deal that could give Alaris a leg-up that will...
Diosynth taps Swiss tech for protein production
29-Jun-2004 - Contract research manufacturer Diosynth has forged a joint venture with a Swiss firm for a technology that could dramatically reduce the time and cost of developing new cell lines for...
Polystyrene price hike to hit packaging sector
29-Jun-2004 - Chemical giant BASF is set to raise its European price for polystyrene (PS) by €200 per metric ton from 1 July this year in response to what it calls totally...
Alliance will make proteins from plants
29-Jun-2004 - Germany's Icon Genetics and Israeli firm Protalix are to collaborate on a way of hiking protein expression in plant cells to improve their use a production vehicle for recombinant proteins.
28-Jun-2004
Novel chemistry could yield improved antisense
28-Jun-2004 - A Korean company has developed a new way of making peptide nucleic acids - a promising drug category that has been limited to date by an expensive and cumbersome synthetic...
ML Labs wins dual inhaler contract
28-Jun-2004 - ML Laboratories of the UK has entered into an agreement to supply an unnamed pharmaceutical company with its C200 metered dose inhaler, designed to deliver two drugs at the same...
Wyeth sells off Indian plant
28-Jun-2004 - The Indian subsidiary of US-based drug major Wyeth has sold its bulk drug manufacturing facility at Ghatkopar in Mumbai to local firm Ariane Orgachem.
First US drug wholesaler adopts RFID
28-Jun-2004 - US-based wholesaler HD Smith has followed the lead of retail giant Wal-Mart in adopting a system of electronic product code (EPC) and radiofrequency identification (RFID) to track controlled pharmaceuticals.
Navigator finds route for microwave synthesis
28-Jun-2004 - Zinsser Analytic and CEM have joined forces to develop an integrated sample preparation system with a built-in microwave system for the synthesis of compounds used in process development or drug...
25-Jun-2004
Merck backs new cancer drug in $350m deal
25-Jun-2004 - A strong indicator of the potential of a new type of drug to treat cancer - the Aurora kinase inhibitors - has come with Merck & Co's decision to invest...
First oral thrombin inhibitor reaches market
25-Jun-2004 - AstraZeneca's anticoagulant Exanta (ximelagatran) has been launched in Germany, its first market worldwide, for the prevention of blood clots in patients undergoing hip or knee replacement surgery.
Discovery heralds better adjuvants
25-Jun-2004 - Adjuvants - substances that are added to vaccines to intensify the immune response to an antigen which have been used for over 80 years - are beginning to be understood...
24-Jun-2004
Roche, GSK ramp up production
24-Jun-2004 - Swiss pharmaceuticals company Roche said it is investing 800 million Swiss francs (€530 million) to build two new manufacturing facilities in Europe.
Ernst & Young on pharma re-imports, pricing
24-Jun-2004 - The pharmaceutical industry must tackle the issue of pricing disparity between countries if it is to avoid having the matter taken out of its hands by government-mandated price cuts and...
Chilean glassmaker plans expansion
24-Jun-2004 - Chilean conglomerate Cristalerias has announced plans to invest $210 million (€173m) over the next 10 years to double its glass container output to 600,000 tonnes a year, the company said in a statement.
Ranbaxy launches chewable cefaclor
24-Jun-2004 - The US subsidiary of India's Ranbaxy has launched a cephalosporin antibiotic in a chewable tablet formulation designed to be easier to take by patients who struggle with tablets or capsules.
Euro drug companies plan R&D cooperation
24-Jun-2004 - A group of research directors of leading pharmaceutical companies met this week to agree a framework for working together on research in a bid to make the European industry more...
Dutch flooring resists chemicals
24-Jun-2004 - Bolidt Synthetic Products and Systems of the Netherlands has launched a new synthetic flooring finish designed specifically to cope with aggressive chemical and pharmaceutical production environments.
Buccal delivery shows further promise
24-Jun-2004 - Canada's Generex Biotechnology has presented new evidence that its RapidMist device can deliver proteins and peptides through the lining of the mouth, potentially doing away with the need for injections.
China proving tough nut for foreign firms?
24-Jun-2004 - Foreign drugmakers are failing to win ground against their local counterparts in China, despite investing considerable sums in the country over the last few years.
New UK centre for stem cell research
24-Jun-2004 - The world's largest centre for human embryonic stem cell research, which will develop treatments for a range of currently incurable diseases, is to be opened by Cambridge University in the...
23-Jun-2004
NIH scientists' in drug firm deal crackdown
23-Jun-2004 - Reforms that demand the public disclosure of industry payments to The National Institute of Health (NIH) employees are to be introduced to crackdown on the violation of existing rules that...
Oral delivery for osteoporosis drug
23-Jun-2004 - Unigene, which specialises in developing oral versions of injectable drugs, has received a $4 million (€3.3m) milestone payment from pharmaceutical major GlaxoSmithKline for starting clinical trials of an osteoporosis drug.
New barrier film from Tekni-Plex
23-Jun-2004 - Tekni-Plex has launched a new range of thermoformable films for blister packaging that is thin, offers high moisture barrier properties and can do away with the need to use environmentally-unsound...
Novel Alzheimer's drug set for clinical trials
23-Jun-2004 - The first clinical trial of a peptide that mimics the cellular adhesion molecule NCAM is due to take place in the UK in the third quarter of this year, bringing...
NovaSeptum samplers upgraded
23-Jun-2004 - NovAseptic has upgraded its NovaSeptum range of disposable samplers to reduce the level of endotoxins to a level that falls well within strict new guidelines set down by the European...
Superfos sticks with pharma unit
23-Jun-2004 - After months of trying to find a partner for its pharmaceutical division, Danish packaging company Superfos has abandoned the plan and will retain the business, reports Phil Taylor.
Sigma-Aldrich buys Tetrionics
23-Jun-2004 - Sigma-Aldrich has boosted its capacity to supply pharmaceutical ingredients with the purchase of Tetrionics, a company with a strong position in the high growth area of high potency and cytotoxic...
22-Jun-2004
India's Bal looks to CIS
22-Jun-2004 - India's Bal Pharma has announced plans to enter the markets of the Commonwealth of Independent States (CIS) and is looking for trade partners and marketing tie-ups in the region for...
Small non-spill connector for chemicals
22-Jun-2004 - Colder Products, a provider of connectors to the processing and packaging industries, has launched a new non-spill connection to meet smaller size requirements in the chemical and other industries.
Pallet cover keeps drugs in shape
22-Jun-2004 - UK company Aerotrim has developed a new line of insulated jackets for pallets that are currently being trialled by pharmaceutical companies and other industries, including food manufacturers and the military.
Holographic approach to anticounterfeiting
22-Jun-2004 - Security Holograms of the US is gearing up to launch a new range of security products designed to protect a range of items from counterfeiting and tampering.
Soaring steel prices hit packaging industry
22-Jun-2004 - Prices for flat rolled steel products in Europe have now in most cases reached their highest level in the last two decades, according to UK steel market analyst MEPS. This...
Tabletop homogeniser for pharma
22-Jun-2004 - Niro Soavi has launched a laboratory tabletop homogeniser that can be used to test homogenisations before scaling-up to industrial applications.
21-Jun-2004
Remote monitor makes API drying a breeze
21-Jun-2004 - A remote controlled camera system that provides continuous monitoring of a key processing machine has achieved a hike in operating efficacy at active pharmaceutical ingredient (API) and fine chemicals company...
Xenova gets OK for UK production site
21-Jun-2004 - UK biotechnology company Xenova has been given regulatory approval for a manufacturing facility for clinical trial materials for its own use, as well as for its clients.
UK eyes pharma industry influence
21-Jun-2004 - In the UK, the House of Commons Health Committee is to undertake a broad-ranging inquiry into the influence of the pharmaceutical industry on health policy, to look for conflicts between...
Heat therapy tackles tumours
21-Jun-2004 - A new treatment for cancer that destroys tumours by heating them from the inside has shown promise in animal studies conducted at Rice University in the US, writes Phil Taylor.
Hanko heads for Degussa
21-Jun-2004 - Rudolf Hanko, formerly head of the fine chemicals business unit at Bayer, has joined Degussa as head of the company's exclusive synthesis business line, part of Degussa's Exclusive Synthesis &...
17-Jun-2004
New player in RNAi reagents
17-Jun-2004 - Germany's MWG Biotech has launched its own line of small interfering RNA (siRNA) reagents, siMAX, encroaching into territory dominated by the likes of Qiagen, Dharmacon, Ambion, Proligo and Invitrogen.
Yeast encapsulator could broaden medical gum use
17-Jun-2004 - Micap, a UK company specialising in using yeast cells to encapsulate drugs, has entered into a collaboration with leading medicated chewing gum company Fertin that should extend the range of...
Magnetic high shear mixer from NovAseptic
17-Jun-2004 - NovAseptic has launched what it claims is the first high shear mixer that uses a magnet-driven mechanism, designed to make it easier to clean and reduce the risk of contamination.
Cholesterol drugs enter genomic age
17-Jun-2004 - Researchers at Harvard have discovered why cholesterol-lowering drugs do not have identical effects on patients. These medicines on average cut heart attacks by a third and with sales of $26...
Irish drug delivery firm Adaptiv goes Stateside
17-Jun-2004 - A new drug delivery company, Merrion Pharmaceuticals, has been set up to commercialise various technologies originally developed at Ireland's Elan, which sold off many of its assets after growing too...
Editors call for drug-trial registry
17-Jun-2004 - A proposal requiring drug companies to register clinical trials in a public database to be considered for later publication - regardless of results - is being considered by top medical...
16-Jun-2004
Try outsourcing to control spiralling R&D budgets
16-Jun-2004 - Companies developing new drugs for the global market must deal with the rising costs of the R&D process - and outsourcing may well be the best route, according to Dr...
Hovione extends drug delivery alliance
16-Jun-2004 - Hovione of Portugal has teamed up with drug delivery company CyDex to develop improved formulations of drugs that have lost or will soon lose patent protection.
Over-boxing the answer to parallel trade risks?
16-Jun-2004 - The European Union parallel trade in pharmaceuticals is offering few benefits to cash-strapped national healthcare systems and may raise the risk of medication errors and entry of counterfeit medicines into...
Trade dress victory for re-packagers
16-Jun-2004 - In Norway, the Supreme Court has concluded that the packaging designused by the local subsidiary of parallel importer Paranova does notinfringe Merck & Co's trademarks.
Debiopharm signs up for insoluble drug delivery tech
16-Jun-2004 - Swiss drugmaker Debiopharm has signed a contract with Labopharm for the application of the latter's nanodelivery system to one of its intravenous cancer drugs.
Lilly hands Elan manufacturing first major contract
16-Jun-2004 - Ireland's Elan has signed its first major contract manufacturing and supply agreement in a development that reinforces its credentials as a player in the outsourcing sector.
Axon releases world's first single-cell electroporator
16-Jun-2004 - Drug discovery instrumentation and software developer Axon Instruments announced today the release of its Axoporator 800A single-cell electroporator, the first commercially available instrument of its kind, writes Wai Lang Chu.
Irish firm adds diversity to chiral catalyst sector
16-Jun-2004 - Irish start-up Celtic Catalysts believes it can tackle two of the major obstacles holding back the use of catalysts to make chiral drugs - the strong patent positions of existing...
EU grant for 3D genomics research
16-Jun-2004 - The European Union has awarded funding worth €2.2 million to the group of academic institutes behind the 3DGENOME research programme, which is exploring how the genome functions in health and disease.
15-Jun-2004
Malta: a rapid route to EU generics market?
15-Jun-2004 - Swiss active pharmaceutical ingredients (API) company Siegfried believes it has found a shortcut on the path to market for generic drugs in the European Union, allowing it to launch drugs...
India clears Neotame for use in drugs
15-Jun-2004 - Neotame, a recently introduced high intensity sweetener developed by US company NutraSweet, has been approved by the health authorities in India for use in pharmaceutical preparations.
Big payload shipper debuts in US
15-Jun-2004 - UK company Laminar Medica has launched a new shipping container for pharmaceuticals that according to tests does not deviate from the set temperature range, even after 450 intercontinental transportations.
Inhaled drug firm plans AIM flotation
15-Jun-2004 - Vectura, a UK biotechnology company which is developing an inhaled alternative to orally acting impotence drugs such as Pfizer's Viagra (sildenafil), has announced plans to float on the London stock...
UK to clone embryos to help diabetics
15-Jun-2004 - Scientists in the UK are tipped to be given approval this week to create cloned human embryos to harvest stem cells to treat diabetes patients and with the possibility of...
14-Jun-2004
Entelos builds in silico model for diabetes
14-Jun-2004 - The development of an in silico model of the non-obese diabetic (NOD) mouse, the primary animal model used by researchers to study type 1 diabetes, is set to enhance understanding...
Galenix plans US expansion
14-Jun-2004 - France's Galenix is to set up a US subsidiary as part of a drive to raise the profile of its drug delivery technologies.
Chemists share synthesis expertise
14-Jun-2004 - An online resource for making organic molecules has been set up by Boston University in the US, to provide a forum for the sharing of information on how to synthesise...
Entry level particle sizer from Malvern
14-Jun-2004 - Malvern Instruments of the UK has launched a new system that is intended as an entry level product for companies needing to size particles in dry powders, suspensions and emulsions.
India adopting barcodes
14-Jun-2004 - The body that oversees the standards relating to product barcoding, EAN, is to work with Indian pharmaceutical companies to help them comply with the US Food and Drug Administration's (FDA)...
Indian API firm boosts Euro presence
14-Jun-2004 - India's Jubilant Organosys has bought two companies in Belgium as part of a drive to improve its presence in the European market for generic drugs and active pharmaceutical ingredients (APIs).
Digital standard could cut approval times
14-Jun-2004 - A coalition of biopharmaceutical companies and regulatory agencies has agreed on an electronic data standard that should make it easier to file product approval dossiers to regulators electronically, bringing drugs...
Water treatment market in Europe
14-Jun-2004 - Membrane separation systems dominate the European market for industrial process water treatment equipment, and the technology looks set to consolidate and spread to Eastern Europe.
11-Jun-2004
Informatics firm achieves profit milestone
11-Jun-2004 - Despite a dip in the fortunes of the biotechnology industry, bioinformatics firm BlueGnome has achieved profit in less than three years since its formation. The firm's fortunes are in contrast...
Chitinase: new drug target in asthma?
11-Jun-2004 - A biomechanical pathway which is key to the specific allergic response suffered by those with asthma has been shown to induce a specific enzyme which if neutralised, could eliminate the...
10-Jun-2004
FDA takes aim at CFC-based MDIs
10-Jun-2004 - The US Food and Drug Administration has suggested removing essential-use status for metered dose inhalers (MDIs) used to deliver the asthma drug albuterol (salbutamol) which use chlorofluorocarbon propellants.
Vaccine preservative safety questioned
10-Jun-2004 - The safety of thiomersal, a preservative that is used in vaccines, has come under scrutiny once again after a study found that it causes damage to nerve cells in newborn...
Alliance seeks animal test alternatives
10-Jun-2004 - Scottish biotech firm CXR biosciences and Edinburgh's Roslin Institute have entered into a collaboration with Geron to develop a new technique that promises to reduce the need to test drugs...
Invitrogen launches first proteome array
10-Jun-2004 - Invitrogen subsidiary Protometrix is gearing up to launch a microarray containing nearly all the 6,200 or so proteins in the proteome of the yeast Saccharomyces cerevisiae, a commonly used organism...
Automation meets process optimisation
10-Jun-2004 - Switzerland's Chemspeed has launched a new workstation that allows up to six reactions to be carried out in parallel, which should speed up process R&D.
09-Jun-2004
Roquette patents mannitol excipient
09-Jun-2004 - French ingredients company Roquette has been granted a US patent for a way to make mannitol a suitable carrier excipient - or pulverulent - for active pharmaceutical ingredients in hard...
Ethypharm signs Japanese deal for FlashTab
09-Jun-2004 - French drug delivery specialist Ethypharm has won a contract to apply its melt-in-the-mouth Flashtab technology to two new over-the-counter analgesic products that will be marketed in Japan by Kowa.
Paper label supports RFID
09-Jun-2004 - Israeli company Power Paper is developing a radio frequency identification (RFID) label that can support sensors for monitoring the pharmaceutical supply chain, according to UK packaging consultancy Pira.
Cardinal Health firms up European presence
09-Jun-2004 - US-based healthcare conglomerate Cardinal Health has stepped up its presence in the European market with the appointment of a new management team for the region based in the UK.
FT-NIR system launched in UK
09-Jun-2004 - The UK subsidiary of Japan's Yokogawa has introduced a new FT-NIR (Fourier transform near infrared) analyser that runs as a stand-alone system, with no need for an attached PC, making...
New R&D service firm eyes Asia
09-Jun-2004 - International R&D group SRI has set up a new company to harvest the growing number of new therapeutic agents in development at bioresearch laboratories in Asia.
08-Jun-2004
New OTC deal in the frame for BioProgress?
08-Jun-2004 - UK encapsulation specialist BioProgress has signed a license option deal for a liquid fill technology with the consumer healthcare division of US drug major Wyeth. If taken to fruition, the...
Hospira expands manufacturing capacity
08-Jun-2004 - Hospira, the hospital products company spun out of Abbott Laboratories earlier this year, has acquired a manufacturing facility that will help it grow its pharmaceutical injectable and outsourcing business.
Israeli scientists unveil new delivery technology
08-Jun-2004 - Despite advances made in sustained delivery drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have...
Three approaches to improving bioprocess yields
08-Jun-2004 - This week has seen three companies put forward different solutions to the topical issue of improving the yield of proteins and nucleic acids made by biomanufacturing technologies.
Industrial biotech leading a green revolution
08-Jun-2004 - The annual US Biotechnology Industry Association event started this weekend in San Francisco with the usual showcase of new biopharmaceuticals and other technologies. But aside from supplying the drugs of...
Researchers discover "fountain-of-youth" gene
08-Jun-2004 - Researchers have isolated a protein that appears to be behind the curious phenomenon that severe dietary restruction can extend the lifespan of some organisms. The protein is thought to control...
3M exits triflic acid market
08-Jun-2004 - 3M will no longer manufacture triflic acid and is closing down its electrochemical fluorination process at the company's Cottage Grove, site in Illinois, US.
07-Jun-2004
RFID helps monitor cold chain
07-Jun-2004 - A number of large pharmaceutical and food manufacturers are piloting a new data logger with radio frequency identification (RFID) technology that is designed to track and monitor the conditions a...
Quadro makes short work of powder dispersions
07-Jun-2004 - Quadro has introduced a new powder disperser designed to incorporate difficult to wet powders into a liquid more efficiently, cutting the amount of powder required by a third and dramatically...
Journal study reveals statistical flaws
07-Jun-2004 - More than one in 10 studies published in peer-reviewed journals contain errors in their statistical analyses which, while often minor, could in some cases compromise study findings.
New database for APIs
07-Jun-2004 - The well established Pharmaceutical Substances database of active pharmaceutical ingredients (APIs), published by Germany's Thieme, is now available for the first time in an online format.
Dutch lab-on-a-chip attracts US firm
07-Jun-2004 - Recently formed US company WaferGen has acquired licenses to three labs-on-a-chip developed at the Technical University of Delft in the Netherlands that could be on the market in the next...
Sandoz empire builds with Sabex buy
07-Jun-2004 - Novartis generics subsidiary Sandoz has continued its expansion with the purchase of Canadian generic drugmaker Sabex Holdings for $565 million (€459m) in cash, bringing in a new range of injectable products.
VEGF inital phase treatments show potential
07-Jun-2004 - Drug therapies that focus on the vascular endothelial growth factor (VEGF) in treating advanced or metastasised cancer represents a huge slice of drug treatments currently in development. This molecular target...
PDE4 re-emerges as depression therapy
07-Jun-2004 - Neuro3d has started trials of its orally active phosphodiesterase-4 (PDE4) inhibitor in depression, resurrecting the use of this class of drug in this indication.
04-Jun-2004
Perbio quadruples Hyclone capacity
04-Jun-2004 - Fisher Scientific subsidiary Perbio last week opened a new facility in the UK to manufacture its Hyclone range of cell culture equipment and mediathat ramps up its liquid production capacity...
Drug candidates previewed ahead of ASCO
04-Jun-2004 - In the build up to the American Society of Clinical Oncology's (ASCO) annual conference, drug companies from around the world have been showcasing potential drug treatments, with a number of...
03-Jun-2004
Strathmann wins cancer contract
03-Jun-2004 - German contract manufacturer Strathmann Biotec has won a contract to manufacture clinical supplies a new type of cancer treatment in development at Sweden's Active Biotech.
Eiffel to accelerate drug re-engineering efforts
03-Jun-2004 - Drug re-engineering company Eiffel Technologies will add to its existing project in improving insulin delivery with the start of clinical trials of an in-house product early next year, writes Wai...
Solutia plans leading role in drug conjugates
03-Jun-2004 - The Pharmaceutical Services Division (PSD) of US chemicals firm Solutia is planning a charge into the market for supplying drug conjugates, which are becoming more and more common in the...
UK backs Onyx API production
03-Jun-2004 - Onyx Scientific has been cleared by the UK authorities for the manufacture of active pharmaceutical ingredients, and says that this approval is one of the first of its kind for...
Cattle antibody production moves a step closer
03-Jun-2004 - Researchers have taken a step forward in the development of a system for making unlimited quantities of antibody-based drugs for human applications in cattle.
02-Jun-2004
Cobra turns to viruses, protein as DNA slumps
02-Jun-2004 - Cobra Biomanufacturing of the UK saw its losses halve in the first half of the current fiscal year, in the face of continuing declines in the market for contract manufacturing...
Peptide blasts fat cells in obese mice
02-Jun-2004 - A new approach to treating obesity that destroys fat tissue using a targeted peptide drug has shown promising results in mice and will move on to non-human primate studies this...
Protein could hold key to cancer spread
02-Jun-2004 - Germany's Xerion Pharmaceuticals has discovered a protein that seems to be intrinsically involved in the spread of cancers and could be a new target for drug therapies. The finding is...
New media for antibody purification
02-Jun-2004 - Millipore has launched a new affinity chromatography media for the capture and purification of high titer antibodies.
Oxoid media for process validation
02-Jun-2004 - Microbiology specialist Oxoid has launched a new soya-based media that is designed for use in media fill trials in the pharmaceutical industry.
Australian nanotech firm eyes drug delivery market
02-Jun-2004 - Australian company pSivida is on the brink of starting clinical trials of a silicon-based nanomaterial that could find broad applications across drug and vaccine delivery, diagnostics and tissue engineering, writes...
Bone-based coating for drugs?
02-Jun-2004 - Canadian company MIV Therapeutics has been awarded a US patent for a coating technology for medical devices and drug encapsulation based on hydroxyapatite, one of the major constituents of bone.
01-Jun-2004
Safer connections from CPC
01-Jun-2004 - A new range of connector accessories for tubing used in the manufacture of pharmaceuticals, designed to improve the safety of processes that need high levels of containment, has been launched...
Rhodia hikes taste-masker production
01-Jun-2004 - Rhodia, the French speciality chemicals company, has expanded its capability to produce N-2,3-trimethyl-2-isopropylbutanamide (more commonly known as WS-23) with the recent addition of a second production stream at its UK...
Reagent cuts proteomics workload
01-Jun-2004 - Applied Biosystems has unveiled a family of reagents that speeds up proteomics and biomarker discovery experiments by allowing up to four peptides to be analysed in single sample, writes Wai...
Protein structure studies at the double
01-Jun-2004 - Formulatrix and Bruker AXS have pooled their resources to speed up the process of high-throughput protein crystallography, a key process in the identification of protein structure and function.
Drug delivery tech could improve haemophilia treatment
01-Jun-2004 - Belgium's Opperbas Holding has started a mid-stage clinical trial of a new formulation of factor VIII - used to treat haemophilia A - that should cut the number of injections...
| « Previous month | Next month » |
Most Popular News
Key Industry Events
Products
On demand Supplier Webinars
Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
ATMI Life Science
